investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best

APELLIS PHARMACEUTICALS INC
(03753U106)

Funds Reporting Holdings of APELLIS PHARMACEUTICALS INC according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
FRED Alger Management Inc 3,000 $76k Jun 30, 2019 Aug 14, 2019
Sectoral Asset Management Inc 1,489,957 $37,756k Jun 30, 2019 Aug 14, 2019
Bailard Inc 15,000 $380k Jun 30, 2019 Jul 26, 2019
Orbimed Advisors LLC 75,000 $1,901k Call Jun 30, 2019 Aug 14, 2019
Westfield Capital Management Company LP 382,212 $9,685k Jun 30, 2019 Aug 13, 2019
Baker BROS Advisors LP 313,725 $7,950k Jun 30, 2019 Aug 14, 2019
VIVO Capital LLC 383,538 $9,719k Jun 30, 2019 Aug 13, 2019
Sofinnova Ventures Inc 49,580 $1,256k Jun 30, 2019 Aug 13, 2019
Hillhouse Capital Management Ltd 2,098,581 $53,178k Jun 30, 2019 Aug 14, 2019
PDT Partners LLC 36,920 $936k Jun 30, 2019 Aug 14, 2019
Regent Investment Management LLC 23,309 $591k Jun 30, 2019 Jul 15, 2019
The Fiduciary Group LLC 255,143 $6,465k Jun 30, 2019 Aug 14, 2019
Point72 Asset Management LP 401,104 $10,164k Jun 30, 2019 Aug 14, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.

Copyright © 2019 by InvestingReview.org / All Rights Reserved.